常用商品分类
服务电话(移)：17319309550
DeepBio得分:5567.2
DeepBio得分
是基于文献引用次数，影响因子，文献新近度等因素计算的客观产品评级，得分越高表明该产品经过越可靠的实验验证，质量可信度越高
66921431
DMSO: 100 mg/mL
Xu, S., et al. 2013. Mol. Cancer Ther.12, 937.
A cell-permeable, orally active, quinoxalinhydrazide derivative that acts an inhibitor of gp130. Binds to gp130 and induces its phosphorylation at Ser782 in ovarian cancer cells (OVCAR-8 and CaoV-3) in a time and dose-dependent manner. Shown to be cytotoxic in a number of ovarian cancer cell lines (IC₅₀ = 720, 490, 950, 440, 530, 88-0, and 430 nM in OVCAR-8, OVCAR-5, OVCAR-3, Caov-3, SKOV-3, HEY, and NCI/ADR-RES cells, respectively). Suppresses constitutive phosphorylation of and nuclear translocation of Stat3. Also blocks LIF and IL-6-induced Akt activation and phosphorylation of Stat3 (Y705) and Stat1 (Y701), without affecting their activation by IFN-γ. Reduces the level downstream effectors of gp130/Stat3 (survivin, MMP-7, Bcl-2, Bcl-xl, and cyclin D1) in ovarian cancer cells. Suppresses the growth of OVCAR-8 tumor xenografts in nude mice without affecting normal tissue (10 mg/kg, i.p. for 58 days). Please note that the molecular weight for this compound is batch-specific due to variable water content.
Primary Target gp130
Toxicity: Standard Handling (A)
| 好评度 | 商品满意度 | 服务满意度 | 发货满意度 |
"5063870001，gp130 Inhibitor, SC144"商品可能已被商家删除，您可查看其他相似商品！
相似产品推荐
购物车（0）
分类纠错
举报
纠错
收 藏
比价
线下结算
公务卡
网银支付
微信
支付宝